MDMA Statement on House Passage of Legislation to Repeal the Medical Device Tax
WASHINGTON, DC – Mark Leahey, President and CEO of the Medical Device Manufacturers Association (MDMA), issued the following statement today regarding bipartisan passage of H.R. 436, the "Health Care Cost Reduction Act of 2012,” which includes repeal of the 2.3% medical device tax, in the U.S. House of Representatives:
"MDMA applauds the House passage of legislation to repeal the medical device tax, and we urge the Senate to act on this important policy for innovators, patients and workers.
"As Congress encourages America’s innovators to create jobs, repeal of the medical device tax is a crucial step to empower medical technology entrepreneurs to answer this challenge. This not only makes good policy, it sends the right message to job-creators that our elected officials are prepared to work on bipartisan proposals to remove the road blocks in their way.
"MDMA thanks Congressman Erik Paulsen and every Member of Congress who serves as a passionate steward of this innovative industry and who continues to fight for an environment where patient care and high-tech manufacturing can thrive.
"The millions of dedicated workers who are a part of this industry have committed themselves to improving the quality of life for patients and to address some of the most daunting challenges in the delivery of care. Repeal of the medical device tax empowers this proud American industry to continue this important work, and will help ensure we remain the world leader in cutting-edge medical technology."